Test Kits That Diagnose Alzheimer’s Early Have Been Developed

There is currently no definitive treatment for Alzheimer’s disease, which millions of people suffer from and causes brain cells to lose their function over time, subsequently causing memory loss, dementia and decreased cognitive functions. However, scientists’ studies show that they are taking steps that can slow the progression of the disease.

currently available Alzheimer’s The feature of the drugs is that they work when taken after the symptoms of the disease appear. Currently available Alzheimer’s diagnosis methods, disease progression Unfortunately, it does not have a big impact on the subject.

Studies carried out by scientists for patients and their relatives with promising developments full. Symptoms of the disease, from the onset of symptoms exactly 20 years can be detected beforehand. Being able to detect the disease so early, during the treatment process can play a big role.

Thanks to studies conducted in America, blood test kits that can diagnose the disease have now been developed. These kits are available upon the request of the patient and the doctor. can be purchased.

There are approximately 55 million Alzheimer’s patients worldwide.

Currently available blood tests for deposits outside the brain, Amyloid-beta 42 and Amyloid-beta 40 It measures two types of proteins named after it. Then the ratios between these two proteins are measured. The lower the ratio, the more likely the person to the disease The higher the probability of being caught.

PrecivityAD This test kit, developed by the company, has been approved for use by doctors in the United States on people showing Alzheimer’s symptoms, and the European Union has approved the use of this test kit on people with Alzheimer’s symptoms. declared that it was safe.

So how can these test kits be used?

In patients with symptoms of the disease, doctors He sends a blood sample to PrecivityAD. Next this blood sample It measures the amyloid-beta ratio. Then, the algorithm the company has established for diagnosis obtains a result by measuring the biomarker levels of the test and taking into account the patient’s age. These results have a scoring system. If as a result of the test high If the score is high, the patient’s risk of Alzheimer’s is high.

The PrecivityAD test has been used in several studies and has found very strong connections with symptoms of the disease. However, the findings It does not mean that the disease can be detected at a hundred percent rate.

Although these tests provide us with preliminary information about the risk of contracting the disease, they do not have as strong an effect as the diagnoses and treatments of specialist doctors. But even the development of such a test is early diagnosis of the disease is of great importance in this regard.

RELATED NEWS

Diseases such as Parkinson’s and Alzheimer’s can be prevented thanks to a new device developed with the support of artificial intelligence

RELATED NEWS

Brain Inflammation Imaged for the First Time: A Gold Discovery for Diseases Such as Parkinson’s and Alzheimer’s…


source site-36